Details of the Drug Formulations

General Information of Drug (ID: DMMP5SI)

• Drug Name: Revefenacin Drug Info
• Synonyms: UNII-G2AE2VE07O; G2AE2VE07O; Revefenacin [INN]; Revefenacin [WHO-DD]; Revefenacin [USAN:INN]; Revefenacin (USAN/INN); SCHEMBL356480; EX-A1722; DB11855; GSK1160724; CS-7743; GSK-1160724; HY-15851; D10978; 1211931-83-7

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Approved	[1]

• Cross-matching ID:
  PubChem CID: 11753673
  CAS Number: 864750-70-9
  TTD ID: D0K1ST
  INTEDE ID: DR1412
  ACDINA ID: D01385

Full List of Drug Formulations Containing This Drug

Revefenacin 175 mcg/3 ml solution

Company	Formulation ID	FDA Description
Mylan Specialty L.P.	F23271	Sodium Chloride; Citric Acid; Sodium Citrate; Water For Injection

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.